Yuko Oya

4PUBLICATIONS
33CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 16, 2024
It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC.

Ken Akao, Yuko Oya, Takaya Sato

|Jun 09, 2021
Novel strategy to treat lung metastases: Hybrid therapy involving surgery and radiofrequency ablation.

Takaaki Hasegawa, Hiroaki Kuroda, Noriaki Sakakura

Pageof 1